Narayana Hrudayalaya539551Quarterly results
Board approves Q2 and H1 FY27 results; auditor's review conclusion unmodified
Board meeting on October 30, 2026 approved the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026.
By ScoutQuest · · 2 min read
| Line item | Latest | Year ago | YoY | Prev qtr | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 28,439.89 | 16,437.90 | +73% | 26,836.34 | +6% |
| Total income | 28,955.31 | 16,677.82 | +73.6% | 27,191.10 | +6.5% |
| Profit before tax | 3,433.45 | 2,954.82 | +16.2% | 2,603.89 | +31.9% |
| Profit after tax | 3,011.53 | 2,584.95 | +16.5% | 2,072.70 | +45.3% |
| Total comprehensive income | 3,632.49 | 3,278.92 | +10.8% | 1,940.45 | +87.2% |
| Basic EPS | 14.82 | 12.72 | +16.5% | 10.20 | +45.3% |
- Total income YoY growth
- +73.6%
- Period
- 30-Sep-26
Auditor's review
Conclusion: Unmodified
Notes to the results
- Exceptional item (Refer Note 8) of (509.54) ₹ million for year ended 31-Mar-26 in consolidated results; standalone note links (452.76) to Labour Codes past service cost.
- Discontinued operations (Refer Note 6): profit for the period from discontinued operations after taxes 2.06 ₹ million in quarter ended 30-Sep-25; (44.80) for year ended 31-Mar-26.
Board meeting outcome
The Board of Directors met on October 30, 2026 from 03:30 P.M. to 05:50 P.M. IST and approved the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, together with the Limited Review Reports.
Auditor's review conclusion
- Deloitte Haskins & Sells LLP reviewed both the standalone and the consolidated statements.
- The conclusion is unmodified: nothing came to the auditor's attention that causes it to believe the statements are not prepared as required.
- A review is narrower in scope than a full audit and is not an audit opinion.
Standalone results, quarter ended September 30 (Rs. in million, current quarter vs year-ago quarter):
- Revenue from operations: 11,853.77 vs 10,191.69
- Total income: 12,287.27 vs 10,362.57
- Earnings before depreciation and amortisation, finance costs and exceptional items (EBITDA): 3,045.61 vs 2,461.39
- Profit before tax: 2,192.22 vs 1,712.95
- Net Profit for the period: 1,756.26 vs 1,378.80
Standalone results, six months ended September 30 (Rs. in million)
- Revenue from operations: 22,824.79 vs 19,623.10
- Net Profit for the period: 3,134.81 vs 2,252.51
Cash and balance sheet (standalone)
- Net cash generated from operating activities: 4,049.53 million in the six months, against 3,342.47 million a year earlier.
- Total assets: 58,917.88 million as at September 30, 2026.
- Total equity: 28,170.49 million.
Key ratios disclosed (standalone)
- Debt equity ratio: 0.74
- Operating margin: 22.04%
- Net profit margin: 14.82%
- Net worth: 28,170.49 million
Other points from the notes
- A final dividend of Rs. 4.50 per equity share of Rs. 10 each, amounting to Rs. 919.62 million for the year ended March 31, 2026, was approved at the Annual General Meeting held on August 14, 2026 and has been paid.
- Scheme of Arrangement for the merger of Meridian Medical Research & Hospital Ltd (MMRHRL) into the company: shareholders of MMRHRL to get 1 equity share of the company for every 2 fully paid-up equity shares of MMRHRL. The scheme was shared with the NCLT, Bengaluru Bench, and the final order is expected.
- Scheme of Arrangement for the demerger of the clinical services undertaking of NH Integrated Care Private Limited (a wholly-owned subsidiary) into the company: no shares will be issued as consideration, as the demerged company is a wholly-owned subsidiary.
- The Labour Codes led to an increase in gratuity and leave liability of Rs. 452.76 million for the year ended March 31, 2026, presented as an exceptional item.
- The company operates in a single segment, Medical and Healthcare Related Services.
28,955.31 (₹ in Million)Total income, latest quarter
Total income, year-ago quarter16,677.82 (₹ in Million)
Total comprehensive income, latest quarter3,632.49 (₹ in Million)
Profit before tax, latest quarter3,433.45 (₹ in Million)
Total comprehensive income, year-ago quarter3,278.92 (₹ in Million)
Total comprehensive income, quarter1,940.45 (₹ in Million)
₹1,756.26 Mn+27.4%
2025₹1,378.80 Mn2026₹1,756.26 Mn
Also from Narayana Hrudayalaya
Q2 FY27 results: consolidated revenue ₹ 28,440 Mn, EBITDA up 42.0% YoY; earnings call on November 2
30 Oct 2026
Narayana Health Q2 FY27: operating revenue up 73.0% YoY to ₹ 28,440 Mn with UK consolidation; targets 7,800+ beds by FY30
30 Oct 2026
Narayana Hrudayalaya to host conference call on Nov 2, 2026 at 3:00 PM IST to discuss Q2/H1 FY27 results
26 Oct 2026
More numbers
- Standalone Revenue from operations, quarter ended Sep 30, 202611,853.77
- Standalone Revenue from operations, quarter ended Sep 30, 202510,191.69
- Standalone Net Profit for the period, quarter ended Sep 30, 20261,756.26
- Standalone Net Profit for the period, quarter ended Sep 30, 20251,378.80
- Final dividend per equity share₹ 4.50
- Final dividend amount₹ 919.62 million
- Labour Codes impact (exceptional item)₹452.76 million
- Net profit margin (standalone)14.82%
- Total income, latest quarter28,955.31 (₹ in Million)
- Total income, year-ago quarter16,677.82 (₹ in Million)
- Total income, previous quarter27,191.10 (₹ in Million)
- Total comprehensive income, latest quarter3,632.49 (₹ in Million)
- Total comprehensive income, year-ago quarter3,278.92 (₹ in Million)
- Total comprehensive income, previous quarter1,940.45 (₹ in Million)
- Profit after tax, latest quarter3,011.53 (₹ in Million)
- Profit after tax, year-ago quarter2,584.95 (₹ in Million)
- Profit after tax, previous quarter2,072.70 (₹ in Million)
- Revenue from operations, latest quarter28,439.89 (₹ in Million)
- Revenue from operations, year-ago quarter16,437.90 (₹ in Million)
- Revenue from operations, previous quarter26,836.34 (₹ in Million)
- Profit before tax, latest quarter3,433.45 (₹ in Million)
- Profit before tax, year-ago quarter2,954.82 (₹ in Million)
- Profit before tax, previous quarter2,603.89 (₹ in Million)
Source: BSE · 30 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.